Shengyu Cui

机构：Capital Medical University, Wuhan University, Renmin Hospital of Wuhan University · ORCID：0000-0001-8371-281X

发表论文 36 篇 · 总被引 565 次 · h-index 15

代表论文

• miR‐145 attenuates cardiac fibrosis through the AKT/GSK‐3β/β‐catenin signaling pathway by directly targeting SOX9 in fibroblasts (2020 · Journal of Cellular Biochemistry · 被引 50)
• Resveratrol alleviates the interleukin-1β-induced chondrocytes injury through the NF-κB signaling pathway (2020 · Journal of Orthopaedic Surgery and Research · 被引 46)
• Activation of sigma-1 receptor ameliorates sepsis-induced myocardial injury by mediating the Nrf2/HO1 signaling pathway to attenuate mitochondrial oxidative stress (2023 · International Immunopharmacology · 被引 27)
• Neuroligin-3 activates Akt-dependent Nrf2 cascade to protect osteoblasts from oxidative stress (2023 · Free Radical Biology and Medicine · 被引 25)
• Fucoxanthin alleviated atherosclerosis by regulating PI3K/AKT and TLR4/NFκB mediated pyroptosis in endothelial cells (2023 · International Immunopharmacology · 被引 25)
• FGF5 protects heart from sepsis injury by attenuating cardiomyocyte pyroptosis through inhibiting CaMKII/NFκB signaling (2022 · Biochemical and Biophysical Research Communications · 被引 22)